Objective:
To provide an expert consensus-based update on cardiovascular abnormalities specifically in Masters athletes and their management.
Approach:
- Masters athletes may have a higher prevalence of cardiovascular abnormalities such as atrial arrhythmias and coronary atherosclerosis, which can complicate management.
- Atrial fibrillation prevalence is higher in Masters athletes, particularly among endurance athletes, necessitating tailored monitoring.
- Coronary calcification is more common in male Masters athletes compared to less active peers, indicating a need for targeted screening.
- Aortic dilatation varies by sport history, with certain sports showing higher prevalence, which may influence management strategies.
- Myocardial fibrosis prevalence varies widely and poses diagnostic challenges, requiring careful interpretation in clinical settings.
- Data on aortic dilatation and myocardial fibrosis are limited and variable, affecting the reliability of conclusions.
- Existing studies often have small sample sizes and selection bias, which may skew results.
- Lack of athlete-specific evidence to guide treatment complicates management decisions.
Key Findings:
Interpretation:
Current management strategies for cardiovascular conditions in Masters athletes may not fully apply due to their unique exercise profiles and physiological adaptations, necessitating a tailored approach.
Limitations:
Conclusion:
Shared decision-making is crucial in managing cardiovascular health in Masters athletes, considering their unique needs, exercise-related risks, and the variability in individual responses.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
